November 7, 2016 / 12:13 PM / 9 months ago

BRIEF-Biocryst Q3 loss $0.16/shr

Nov 7 (Reuters) - Biocryst Pharmaceuticals Inc

* Biocryst reports third quarter 2016 financial results

* Q3 loss per share $0.16

* Q3 revenue $7.8 million versus $11 million

* Q3 revenue view $5.8 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S

* Biocryst Pharmaceuticals Inc says continues to expect its 2016 net operating cash use to be in range of $55 to $75 million

* Biocryst Pharmaceuticals Inc says revised its 2016 operating expenses outlook to be in range of $68 to $80 million

* Biocryst Pharmaceuticals Inc - Biocryst continues to expect its 2016 net operating cash use to be in range of $55 to $75 million

* Biocryst Pharmaceuticals - 2016 operating expenses to now be in range of $68 to $80 million, a reduction from previous forecasted range of $78 to $98 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below